A preventative vaccine for the Ebola virus could be available as early next year, as British pharma company GlaxoSmithKline prepares for clinical trials of the preparation.
The WHO announced Saturday the trials could begin as early as next month and the vaccine could be available by 2015.
There is currently no available cure or vaccine for Ebola, a virus that causes severe fever and, in the worst cases, unstoppable bleeding.
It has claimed close to 1-thousand lives in the latest epidemic to spread across West Africa this year.
Fatality rates can approach 90 percent, although the latest outbreak has killed around 55 to 60 percent of those infected.
본 저작물 중 본문에 해당하는 뉴스 스크립트는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.
단, 영상 자료는 저작권 문제로 자유이용이 제한되니, 담당자에게 확인하여 주시기 바랍니다.
(국제방송교류재단 김형선 : ☎02-3475-5263)